Company Filing History:
2 out of 832,966 Years Active: 2017-2018
Title: The Innovations of Hamed Abiri in Cancer Diagnosis
Introduction
Hamed Abiri, an inventive mind based in Tehran, Iran, has significantly contributed to the field of medical diagnostics through his innovative patents. With two patents to his name, Abiri's work focuses on developing advanced technologies for cancer diagnosis and treatment monitoring.
Latest Patents
Abiri's latest patents revolve around the Electrical Cell-Substrate Impedance Sensor (ECIS), which provides groundbreaking methods for cancer diagnosis. The first patent delineates a method to detect and monitor the spreading stage of biological cells. This process involves removing biological cell lines, culturing them under controlled conditions, and then seeding them on silicon nanowire electrode arrays of an ECIS. Finally, by measuring the electrical impedance of these cells, Abiri's method aims at facilitating early cancer diagnosis.
His second patent addresses the therapeutic effects of cancer treatment drugs. This method similarly starts with the extraction and culturing of malignant biological cell lines from tumors. Once seeded onto silicon nanowire electrode arrays, a cancer treatment drug is administered. The measurement of electrical impedance then assists in detecting and monitoring the therapeutic effects of the administered drug.
Career Highlights
Abiri's career has been marked by his dedication to improving cancer diagnosis methods. His inventive approaches through the ECIS have the potential to revolutionize how clinicians assess and monitor cancer therapies, paving the way for more effective treatments.
Collaborations
Throughout his journey, Hamed Abiri has collaborated with various talented individuals, including Mohammad Abdolahad and Milad Gharooni. Their combined expertise and teamwork have been crucial in advancing the innovative solutions that Abiri has proposed in his patents.
Conclusion
Hamed Abiri's contributions through his patents represent a significant step forward in medical technology, particularly in cancer diagnosis and treatment monitoring. His innovative methods promise to enhance the accuracy of cancer assessments and improve patient care, affirming the importance of continuous research and innovation in the medical field.